Structural studies of human extracellular calcium-sensing receptor
人细胞外钙敏感受体的结构研究
基本信息
- 批准号:9293333
- 负责人:
- 金额:$ 31.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAgonistAlzheimer&aposs DiseaseAmino AcidsBindingBinding SitesBiological ProcessBone DiseasesCalciumCalcium-Sensing ReceptorsCalmodulinCell ExtractsCell membraneCell surfaceCellsClinicalComplexCryoelectron MicroscopyCrystallizationCytoplasmic ReceptorsCytoplasmic TailDetergentsDimerizationDiseaseDisulfidesEquilibriumEventExhibitsExtracellular DomainFetal DevelopmentG-Protein-Coupled ReceptorsG-substrateGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGoalsHeterotrimeric GTP-Binding ProteinsHomeostasisHomodimerizationHomology ModelingHumanInositol PhosphatesInsectaIntracellular Signaling ProteinsIonsLeadLengthLifeLigand BindingLigandsMaintenanceMalignant NeoplasmsMammalian CellMapsMeasuresMetabolismMethodsMineralsMolecularMolecular ConformationMonitorMutationPTH genePhenylalaninePhysiologicalPlayProteinsReceptor ActivationReceptor GeneRegulationResearchRestRoleSignal PathwaySignal TransductionSignaling MoleculeSiteSpecificityStimulusStructural ModelsStructureSystemTherapeutic AgentsTransmembrane DomainX-Ray Crystallographybasecinacalcetdesigndetection of nutrientdimerextracellularinformation modelneuronal excitabilitynovel therapeuticspublic health relevancereceptorreceptor functionresponse
项目摘要
DESCRIPTION (provided by applicant): Human extracellular calcium-sensing receptor (CaSR) is a G-protein coupled receptor that maintains Ca2+ homeostasis through the regulation of parathyroid hormone secretion. CaSR also plays important roles in biological processes unrelated to Ca2+ balance such as fetal development. Abnormalities in the CaSR gene are associated with a vareity of Ca2+ homeostatic disorders including potentially life threatening hypercalcaemic conditions. Altered expression of CaSR has also been implicated in other diseases including cancer and Alzheimer's disease. Cinacalcet, an allosteric modulator of CaSR, is used clinically to treat disorders of bone and mineral metabolism. Therefore, elucidating the structure of CaSR may assist the design of valuable therapeutic agents. CaSR functions as a disulfide-tethered homodimer. It activates a diverse array of signaling pathways in a ligand-specific manner. In addition to its principal agonist, extracellular Ca2+, CaSR responds to a variety of agonists, and its activity is regulated by postive and negative allosteric modulators. The first part of this proposal is aimed at understanding the mechanisms by which CaSR recognizes structurally distinct ligands while maintaining binding affinity and specificity. We propose to solve the crystal structures of CaSR ectodomain bound to different agonists and allosteric modulators. The second aim is to identify the conformational changes associated with receptor activation based on the structures of CaSR ectodomain in the resting and active states. We plan to measure the functional effects of mutations that are designed based on these structures to probe the ligand binding sites and homodimer interface. The third part of the proposed research is to elucidate the signal transduction mechanism of CaSR by solving the structures of full-length receptor and its complexes with downstream signaling molecules. A combination of structural and functional analysis of CaSR will advance our understanding of the molecular basis of extracellular Ca2+ sensing and the general activation mechanisms of GPCR dimers.
描述(由适用提供):人类细胞外钙 - 感应受体(CASR)是一种G蛋白耦合受体,通过调节甲状旁腺同位分泌来维持Ca2+稳态。 CASR还在与Ca2+平衡无关的生物过程中起着重要作用,例如胎儿发育。 CASR基因的异常与CA2+稳态疾病的危险有关,包括潜在威胁生命的高钙血症状况。 CASR表达的改变也已在包括癌症和阿尔茨海默氏病在内的其他疾病中浸渍。 CANACALCET是CASR的变构调节剂,在临床上用于治疗骨骼和矿物质代谢疾病。因此,阐明CASR的结构可以帮助设计有价值的治疗剂。 CASR充当二硫键均匀二聚体。它以配体特异性方式激活潜水员的信号通路。除了其主要激动剂外,CASR还对各种激动剂做出了反应,其活性受后期和负变构调节剂的调节。该提案的第一部分旨在理解CASR在保持结构上不同的配体同时保持结合亲和力和特异性的机制。我们建议解决与不同激动剂和变构调节剂结合的CASR外生域的晶体结构。第二个目的是确定基于静息和活性状态中CASR外域的结构与受体激活相关的会议变化。我们计划测量基于这些结构设计的突变的功能效应,以探测配体结合位点和同型二聚体界面。拟议的研究的第三部分是通过求解具有下游信号分子的全长接收器及其复合物的结构来阐明CASR的信号传递机制。 CASR的结构和功能分析的结合将提高我们对细胞外Ca2+灵敏度的分子基础的理解以及GPCR二聚体的一般激活机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
QING R FAN其他文献
QING R FAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('QING R FAN', 18)}}的其他基金
Molecular mechanism of dimeric G protein-coupled receptor signaling
二聚体G蛋白偶联受体信号传导的分子机制
- 批准号:
10207012 - 财政年份:2021
- 资助金额:
$ 31.6万 - 项目类别:
Molecular mechanism of dimeric G protein-coupled receptor signaling
二聚体G蛋白偶联受体信号传导的分子机制
- 批准号:
10582139 - 财政年份:2021
- 资助金额:
$ 31.6万 - 项目类别:
Molecular mechanism of dimeric G protein-coupled receptor signaling
二聚体G蛋白偶联受体信号传导的分子机制
- 批准号:
10382430 - 财政年份:2021
- 资助金额:
$ 31.6万 - 项目类别:
Molecular mechanism of dimeric G protein-coupled receptor signaling
二聚体G蛋白偶联受体信号传导的分子机制
- 批准号:
10588166 - 财政年份:2021
- 资助金额:
$ 31.6万 - 项目类别:
Mechanism of activation and modulation in human GABA(B) receptor
人 GABA(B) 受体的激活和调节机制
- 批准号:
9982345 - 财政年份:2018
- 资助金额:
$ 31.6万 - 项目类别:
Mechanism of activation and modulation in human GABA(B) receptor
人 GABA(B) 受体的激活和调节机制
- 批准号:
10224896 - 财政年份:2018
- 资助金额:
$ 31.6万 - 项目类别:
Mechanism of activation and modulation in human GABA(B) receptor
人 GABA(B) 受体的激活和调节机制
- 批准号:
10388693 - 财政年份:2018
- 资助金额:
$ 31.6万 - 项目类别:
Structural Studies of Metabotropic GABA Receptors
代谢型 GABA 受体的结构研究
- 批准号:
7915372 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Structural Studies of Metabotropic GABA Receptors
代谢型 GABA 受体的结构研究
- 批准号:
8118530 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Structural Studies of Metabotropic GABA Receptors
代谢型 GABA 受体的结构研究
- 批准号:
8513349 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Development of first-in-class antagonists of the retinoid pathway as novel oral therapies for Type 2 Diabetes
开发类视黄醇途径的一流拮抗剂作为 2 型糖尿病的新型口服疗法
- 批准号:
10699637 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别:
Sigma 2 Receptor (TMEM97): Investigating the Peripheral Role of this Novel Therapeutic Target for Pain
Sigma 2 受体 (TMEM97):研究这种新型疼痛治疗靶点的外周作用
- 批准号:
10607436 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别: